|
2021
|
Invention
|
Methods and compositions for the treatment of seizure-related disorders.
Compositions and method... |
|
|
Invention
|
Composition and method for treating neurological disease. The present disclosure is directed to m... |
|
2019
|
Invention
|
Composition and method for treating neurological disease.
The present disclosure is directed to ... |
|
2018
|
Invention
|
Methods and compositions for the treatment of seizure-related disorders. Compositions and methods... |
|
2016
|
Invention
|
Compositions for the treatment of cns-related conditions.
The invention provides methods for tre... |
|
2015
|
Invention
|
Methods of administering amantadine compositions. Methods of administration of amantadine to impr... |
|
|
Invention
|
Composition and method for treating neurological disease.
Disclosed are compositions comprising ... |
|
|
Invention
|
Amantadine compositions and methods of use.
Methods of nighttime administration of amantadine to... |
|
2014
|
Invention
|
Method for administering an nmda receptor antagonist to a subject.
Compositions and methods for ... |
|
|
Invention
|
Amantadine compositions and methods of use. Methods of nighttime administration of amantadine to ... |
|
2013
|
Invention
|
Composition for administering an nmda receptor antagonist to a subject.
The invention provides e... |
|
|
Invention
|
Composition and method for treating neurological disease.
A method of treating a patient with Pa... |
|
2012
|
Invention
|
Methods for the treatment of cns-related conditions.
The invention provides methods for treating... |
|
2011
|
Invention
|
Compositions and kits for treating influenza.
Compositions, kits and methods are provided for th... |
|
2010
|
Invention
|
Method and composition for administering an nmda receptor antagonist to a subject.
The invention... |
|
2009
|
P/S
|
Pharmaceutical preparations. |
